Pregnancy-associated changes in urinary uromodulin excretion in chronic hypertension.
Blood pressure
Chronic hypertensive pregnancy
Kidney physiology
Uromodulin
Journal
Journal of nephrology
ISSN: 1724-6059
Titre abrégé: J Nephrol
Pays: Italy
ID NLM: 9012268
Informations de publication
Date de publication:
18 Jan 2024
18 Jan 2024
Historique:
received:
08
05
2023
accepted:
10
11
2023
medline:
18
1
2024
pubmed:
18
1
2024
entrez:
18
1
2024
Statut:
aheadofprint
Résumé
Pregnancy involves major adaptations in renal haemodynamics, tubular, and endocrine functions. Hypertensive disorders of pregnancy are a leading cause of maternal mortality and morbidity. Uromodulin is a nephron-derived protein that is associated with hypertension and kidney diseases. Here we study the role of urinary uromodulin excretion in hypertensive pregnancy. Urinary uromodulin was measured by ELISA in 146 pregnant women with treated chronic hypertension (n = 118) and controls (n = 28). We studied non-pregnant and pregnant Wistar Kyoto and Stroke Prone Spontaneously Hypertensive rats (n = 8/strain), among which a group of pregnant Stroke-Prone Spontaneously Hypertensive rats was treated with either nifedipine (n = 7) or propranolol (n = 8). In pregnant women, diagnosis of chronic hypertension, increased maternal body mass index, Black maternal ethnicity and elevated systolic blood pressure at the first antenatal visit were significantly associated with a lower urinary uromodulin-to-creatinine ratio. In rodents, pre-pregnancy urinary uromodulin excretion was twofold lower in Stroke-Prone Spontaneously Hypertensive rats than in Wistar Kyoto rats. During pregnancy, the urinary uromodulin excretion rate gradually decreased in Wistar Kyoto rats (a twofold decrease), whereas a 1.5-fold increase was observed in Stroke-Prone Spontaneously Hypertensive rats compared to pre-pregnancy levels. Changes in uromodulin were attributed by kidney injury in pregnant rats. Neither antihypertensive changed urinary uromodulin excretion rate in pregnant Stroke-Prone Spontaneously Hypertensive rats. In summary, we demonstrate pregnancy-associated differences in urinary uromodulin: creatinine ratio and uromodulin excretion rate between chronic hypertensive and normotensive pregnancies. Further research is needed to fully understand uromodulin physiology in human pregnancy and establish uromodulin's potential as a biomarker for renal adaptation and renal function in pregnancy.
Sections du résumé
BACKGROUND
BACKGROUND
Pregnancy involves major adaptations in renal haemodynamics, tubular, and endocrine functions. Hypertensive disorders of pregnancy are a leading cause of maternal mortality and morbidity. Uromodulin is a nephron-derived protein that is associated with hypertension and kidney diseases. Here we study the role of urinary uromodulin excretion in hypertensive pregnancy.
METHODS
METHODS
Urinary uromodulin was measured by ELISA in 146 pregnant women with treated chronic hypertension (n = 118) and controls (n = 28). We studied non-pregnant and pregnant Wistar Kyoto and Stroke Prone Spontaneously Hypertensive rats (n = 8/strain), among which a group of pregnant Stroke-Prone Spontaneously Hypertensive rats was treated with either nifedipine (n = 7) or propranolol (n = 8).
RESULTS
RESULTS
In pregnant women, diagnosis of chronic hypertension, increased maternal body mass index, Black maternal ethnicity and elevated systolic blood pressure at the first antenatal visit were significantly associated with a lower urinary uromodulin-to-creatinine ratio. In rodents, pre-pregnancy urinary uromodulin excretion was twofold lower in Stroke-Prone Spontaneously Hypertensive rats than in Wistar Kyoto rats. During pregnancy, the urinary uromodulin excretion rate gradually decreased in Wistar Kyoto rats (a twofold decrease), whereas a 1.5-fold increase was observed in Stroke-Prone Spontaneously Hypertensive rats compared to pre-pregnancy levels. Changes in uromodulin were attributed by kidney injury in pregnant rats. Neither antihypertensive changed urinary uromodulin excretion rate in pregnant Stroke-Prone Spontaneously Hypertensive rats.
CONCLUSIONS
CONCLUSIONS
In summary, we demonstrate pregnancy-associated differences in urinary uromodulin: creatinine ratio and uromodulin excretion rate between chronic hypertensive and normotensive pregnancies. Further research is needed to fully understand uromodulin physiology in human pregnancy and establish uromodulin's potential as a biomarker for renal adaptation and renal function in pregnancy.
Identifiants
pubmed: 38236469
doi: 10.1007/s40620-023-01830-6
pii: 10.1007/s40620-023-01830-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Academy of Medical Sciences
ID : NIF004\1010
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/18/6/34217
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/18/58/34179
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 221774/Z/20/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V006835/1
Pays : United Kingdom
Informations de copyright
© 2024. The Author(s).
Références
Seely EW, Ecker J (2014) Chronic hypertension in pregnancy. Circulation 129:1254–1261. https://doi.org/10.1161/CIRCULATIONAHA.113.003904
doi: 10.1161/CIRCULATIONAHA.113.003904
pubmed: 24637432
Bateman BT, Bansil P, Hernandez-Diaz S, Mhyre JM, Callaghan WM, Kuklina EV (2012) Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol 206(134):e131-138. https://doi.org/10.1016/j.ajog.2011.10.878
doi: 10.1016/j.ajog.2011.10.878
Poston L, Caleyachetty R, Cnattingius S, Corvalan C, Uauy R, Herring S, Gillman MW (2016) Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol 4:1025–1036. https://doi.org/10.1016/S2213-8587(16)30217-0
doi: 10.1016/S2213-8587(16)30217-0
pubmed: 27743975
Al Khalaf SY, O’reilly EJ, Barrett PM, Df BL, Pawley LC, Mccarthy FP, Khashan AS (2021) Impact of chronic hypertension and antihypertensive treatment on adverse perinatal outcomes: systematic review and meta-analysis. J Am Heart Assoc 10:e018494. https://doi.org/10.1161/JAHA.120.018494
doi: 10.1161/JAHA.120.018494
pubmed: 33870708
pmcid: 8200761
Bulletins ACOP (2001) ACOG practice bulletin. Chronic hypertension in pregnancy. ACOG Committee on Practice Bulletins. Obstet Gynecol. https://doi.org/10.1016/s0029-7844(01)01471-5
doi: 10.1016/s0029-7844(01)01471-5
Bramham K, Parnell B, Nelson-Piercy C, Seed PT, Poston L, Chappell LC (2014) Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ 348:g2301. https://doi.org/10.1136/bmj.g2301
doi: 10.1136/bmj.g2301
pubmed: 24735917
pmcid: 3988319
Prakash J (2012) The kidney in pregnancy: a journey of three decades. Indian J Nephrol 22:159–167. https://doi.org/10.4103/0971-4065.98750
doi: 10.4103/0971-4065.98750
pubmed: 23087548
pmcid: 3459517
Barrett PM, Mccarthy FP, Evans M, Kublickas M, Perry IJ, Stenvinkel P, Khashan AS, Kublickiene K (2020) Hypertensive disorders of pregnancy and the risk of chronic kidney disease: a Swedish registry-based cohort study. PLoS Med 17:e1003255. https://doi.org/10.1371/journal.pmed.1003255
doi: 10.1371/journal.pmed.1003255
pubmed: 32797043
pmcid: 7428061
Yee LM, Miller EC, Greenland P (2022) Mitigating the long-term health risks of adverse pregnancy outcomes. JAMA 327:421–422. https://doi.org/10.1001/jama.2021.23870
doi: 10.1001/jama.2021.23870
pubmed: 35024771
Cho L, Davis M, Elgendy I et al (2020) Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review. J Am Coll Cardiol 75:2602–2618. https://doi.org/10.1016/j.jacc.2020.03.060
doi: 10.1016/j.jacc.2020.03.060
pubmed: 32439010
pmcid: 8328156
Devuyst O, Olinger E, Rampoldi L (2017) Uromodulin: from physiology to rare and complex kidney disorders. Nat Rev Nephrol 13:525–544. https://doi.org/10.1038/nrneph.2017.101
doi: 10.1038/nrneph.2017.101
pubmed: 28781372
Padmanabhan S, Graham L, Ferreri NR, Graham D, Mcbride M, Dominiczak AF (2014) Uromodulin, an emerging novel pathway for blood pressure regulation and hypertension. Hypertension 64:918–923. https://doi.org/10.1161/HYPERTENSIONAHA.114.03132
doi: 10.1161/HYPERTENSIONAHA.114.03132
pubmed: 25110906
Schaeffer C, Devuyst O, Rampoldi L (2021) Uromodulin: roles in health and disease. Ann Rev Physiol 83:477–501. https://doi.org/10.1146/annurev-physiol-031620-092817
doi: 10.1146/annurev-physiol-031620-092817
Padmanabhan S, Melander O, Johnson T et al (2010) Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet 6:e1001177. https://doi.org/10.1371/journal.pgen.1001177
doi: 10.1371/journal.pgen.1001177
pubmed: 21082022
pmcid: 2965757
Trudu M, Janas S, Lanzani C et al (2013) Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med 19:1655–1660. https://doi.org/10.1038/nm.3384
doi: 10.1038/nm.3384
pubmed: 24185693
Boder P, Mary S, Mark PB, Leiper J, Dominiczak AF, Padmanabhan S, Rampoldi L, Delles C (2021) Mechanistic interactions of uromodulin with the thick ascending limb: perspectives in physiology and hypertension. J Hypertens 39:1490. https://doi.org/10.1097/HJH.0000000000002861
doi: 10.1097/HJH.0000000000002861
pubmed: 34187999
pmcid: 7611110
Mary S, Boder P, Padmanabhan S, Mcbride MW, Graham D, Delles C, Dominiczak AF (2022) Role of uromodulin in salt-sensitive hypertension. Hypertension 79:2419–2429. https://doi.org/10.1161/HYPERTENSIONAHA.122.19888
doi: 10.1161/HYPERTENSIONAHA.122.19888
pubmed: 36378920
Pruijm M, Ponte B, Ackermann D et al (2016) Associations of urinary uromodulin with clinical characteristics and markers of tubular function in the general population. Clin J Am Soc Nephrol 11:70–80. https://doi.org/10.2215/CJN.04230415
doi: 10.2215/CJN.04230415
pubmed: 26683888
Wiles K, Bramham K, Seed PT, Nelson-Piercy C, Lightstone L, Chappell LC (2019) Serum creatinine in pregnancy: a systematic review. Kidney Int Rep 4:408–419. https://doi.org/10.1016/j.ekir.2018.10.015
doi: 10.1016/j.ekir.2018.10.015
pubmed: 30899868
Carty DM, Siwy J, Brennand JE et al (2011) Urinary proteomics for prediction of preeclampsia. Hypertension 57:561–569. https://doi.org/10.1161/HYPERTENSIONAHA.110.164285
doi: 10.1161/HYPERTENSIONAHA.110.164285
pubmed: 21199994
Kononikhin AS, Starodubtseva NL, Bugrova AE et al (2016) An untargeted approach for the analysis of the urine peptidome of women with preeclampsia. J Proteom 149:38–43. https://doi.org/10.1016/j.jprot.2016.04.024
doi: 10.1016/j.jprot.2016.04.024
Kononikhin AS, Zakharova NV, Sergeeva VA et al (2020) Differential diagnosis of preeclampsia based on urine peptidome features revealed by high resolution mass spectrometry. Diagnostics 10:1039. https://doi.org/10.3390/diagnostics10121039
doi: 10.3390/diagnostics10121039
pubmed: 33287124
pmcid: 7761751
Shibukawa T, Horie R, Kitao M, Yamori Y (1990) Stroke-prone spontaneously hypertensive rats as a model for toxemia of pregnancy and aggravating and preventive effects of maternal modifications during pregnancy on offspring’s growth. Jpn Circ J 54:644–652. https://doi.org/10.1253/jcj.54.644
doi: 10.1253/jcj.54.644
pubmed: 2232119
Churchill PC, Churchill MC, Griffin KA, Picken M, Webb RC, Kurtz TW, Bidani AK (2002) Increased genetic susceptibility to renal damage in the stroke-prone spontaneously hypertensive rat. Kidney Int 61:1794–1800. https://doi.org/10.1046/j.1523-1755.2002.00321.x
doi: 10.1046/j.1523-1755.2002.00321.x
pubmed: 11967029
Mary S, Small H, Herse F, Carrick E, Flynn A, Mullen W, Dechend R, Delles C (2021) Preexisting hypertension and pregnancy-induced hypertension reveal molecular differences in placental proteome in rodents. Physiol Genomics 53:259–268. https://doi.org/10.1152/physiolgenomics.00160.2020
doi: 10.1152/physiolgenomics.00160.2020
pubmed: 33969702
pmcid: 8616587
Small HY, Morgan H, Beattie E, Griffin S, Indahl M, Delles C, Graham D (2016) Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat. Placenta 37:34–44. https://doi.org/10.1016/j.placenta.2015.10.022
doi: 10.1016/j.placenta.2015.10.022
pubmed: 26612342
pmcid: 4721537
Yamada N, Kido K, Tamai T, Mukai M, Hayashi S (1981) Hypertensive effects on pregnancy in spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP). Int J Biol Res Pregnancy 2:80–84
pubmed: 7333695
Cabarcas-Barbosa O, Capalbo O, Ferrero-Fernández A, Musso CG (2022) Kidney–placenta crosstalk in health and disease. Clin Kid J. https://doi.org/10.1093/ckj/sfac060
doi: 10.1093/ckj/sfac060
Barrientos G, Pussetto M, Rose M, Staff A, Blois S, Toblli JE (2017) Defective trophoblast invasion underlies fetal growth restriction and preeclampsia-like symptoms in the stroke-prone spontaneously hypertensive rat. Mol Hum Reprod 23:509–519. https://doi.org/10.1093/molehr/gax024
doi: 10.1093/molehr/gax024
pubmed: 28402512
Morgan HL, Butler E, Ritchie S, Herse F, Dechend R, Beattie E, Mcbride MW, Graham D (2018) Modeling superimposed preeclampsia using Ang II (Angiotensin II) infusion in pregnant stroke-prone spontaneously hypertensive rats. Hypertension 72:208–218. https://doi.org/10.1161/HYPERTENSIONAHA.118.10935
doi: 10.1161/HYPERTENSIONAHA.118.10935
pubmed: 29844145
Webster LM, Myers JE, Nelson-Piercy C et al (2017) Labetalol versus nifedipine as antihypertensive treatment for chronic hypertension in pregnancy: a randomized controlled trial. Hypertension 70:915–922. https://doi.org/10.1161/HYPERTENSIONAHA.117.09972
doi: 10.1161/HYPERTENSIONAHA.117.09972
pubmed: 28893900
Bramham K, Seed PT, Lightstone L, Nelson-Piercy C, Gill C, Webster P, Poston L, Chappell LC (2016) Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89:874–885. https://doi.org/10.1016/j.kint.2015.10.012
doi: 10.1016/j.kint.2015.10.012
pubmed: 26924064
Tranquilli AL, Dekker G, Magee L, Roberts J, Sibai BM, Steyn W, Zeeman GG, Brown MA (2014) The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens 4:97–104. https://doi.org/10.1016/j.preghy.2014.02.001
doi: 10.1016/j.preghy.2014.02.001
pubmed: 26104417
Team RC (2013) R: A language and environment for statistical computing.
Bates D, Mächler M, Bolker B, Walker S (2014) Fitting linear mixed-effects models using lme4. https://doi.org/10.18637/jss.v067.i01. arXiv preprint arXiv:1406.5823
Schoenfeld N, Epstein O, Nemesh L, Rosen M, Atsmon A (1978) Effects of propranolol during pregnancy and development of rats. I. Adverse effects during pregnancy. Pediatr Res 12:747–750. https://doi.org/10.1203/00006450-197807000-00001
doi: 10.1203/00006450-197807000-00001
pubmed: 693116
Evans AL, Brown W, Kenyon CJ, Maxted KJ, Smith DC (1994) Improved system for measuring systolic blood pressure in the conscious rat. Med Biol Eng Comput 32:101–102. https://doi.org/10.1007/BF02512487
doi: 10.1007/BF02512487
pubmed: 8182951
Lafavers KA, Micanovic R, Sabo AR, Maghak LA, El-Achkar TM (2022) Evolving concepts in uromodulin biology, physiology, and its role in disease: a tale of two forms. Hypertension 79:2409–2418. https://doi.org/10.1161/HYPERTENSIONAHA.122.18567
doi: 10.1161/HYPERTENSIONAHA.122.18567
pubmed: 35959659
Mary S, Small HY, Siwy J, Mullen W, Giri A, Delles C (2017) Polymerization-incompetent uromodulin in the pregnant stroke-prone spontaneously hypertensive rat. Hypertension 69:910–918. https://doi.org/10.1161/HYPERTENSIONAHA.116.08826
doi: 10.1161/HYPERTENSIONAHA.116.08826
pubmed: 28348009
Steubl D, Block M, Herbst V et al (2016) Plasma uromodulin correlates with kidney function and identifies early stages in chronic kidney disease patients. Med (Baltim) 95:e3011. https://doi.org/10.1097/MD.0000000000003011
doi: 10.1097/MD.0000000000003011
De Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL, Group PS (2002) Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 26(Suppl 4):S21-24. https://doi.org/10.1038/sj.ijo.0802213
doi: 10.1038/sj.ijo.0802213
pubmed: 12457295
Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM (2005) Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46:871–880. https://doi.org/10.1053/j.ajkd.2005.08.015
doi: 10.1053/j.ajkd.2005.08.015
pubmed: 16253727
Iseki K, Tokashiki K, Iseki C, Kohagura K, Kinjo K, Takishita S (2008) Proteinuria and decreased body mass index as a significant risk factor in developing end-stage renal disease. Clin Exp Nephrol 12:363–369. https://doi.org/10.1007/s10157-008-0061-6
doi: 10.1007/s10157-008-0061-6
pubmed: 18584288
Hsu CY, Mcculloch CE, Iribarren C, Darbinian J, Go AS (2006) Body mass index and risk for end-stage renal disease. Ann Intern Med 144:21–28. https://doi.org/10.7326/0003-4819-144-1-200601030-00006
doi: 10.7326/0003-4819-144-1-200601030-00006
pubmed: 16389251
Bosma RJ, Krikken JA, Homan Van Der Heide JJ, De Jong PE, Navis GJ (2006) Obesity and renal hemodynamics. Contrib Nephrol 151:184–202. https://doi.org/10.1159/000095329
doi: 10.1159/000095329
pubmed: 16929142
Bosma RJ, Homan JJ, Heide V, Oosterop EJ, De Jong PE, Navis G (2004) Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 65:259–265. https://doi.org/10.1111/j.1523-1755.2004.00351.x
doi: 10.1111/j.1523-1755.2004.00351.x
pubmed: 14675058
Frohlich ED, Susic D (2008) Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension. Curr Hypertens Rep 10:151–155. https://doi.org/10.1007/s11906-008-0028-8
doi: 10.1007/s11906-008-0028-8
pubmed: 18474183
Savitri AI, Zuithoff P, Browne JL, Amelia D, Baharuddin M, Grobbee DE, Uiterwaal CS (2016) Does pre-pregnancy BMI determine blood pressure during pregnancy? A prospective cohort study. BMJ Open 6:e011626. https://doi.org/10.1136/bmjopen-2016-011626
doi: 10.1136/bmjopen-2016-011626
pubmed: 27515754
pmcid: 4985806
Parsa A, Kao WH, Xie D et al (2013) APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 369:2183–2196. https://doi.org/10.1056/NEJMoa1310345
doi: 10.1056/NEJMoa1310345
pubmed: 24206458
pmcid: 3969022
Hung RKY, Santana-Suarez B, Binns-Roemer E et al (2021) The epidemiology of kidney disease in people of African ancestry with HIV in the UK. EClinicalMedicine 38:101006. https://doi.org/10.1016/j.eclinm.2021.101006
doi: 10.1016/j.eclinm.2021.101006
pubmed: 34286237
pmcid: 8273351
Tayo BO, Kramer H, Salako BL, Gottesman O, Mckenzie CA, Ogunniyi A, Bottinger EP, Cooper RS (2013) Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians. Int Urol Nephrol 45:485–494. https://doi.org/10.1007/s11255-012-0263-4
doi: 10.1007/s11255-012-0263-4
pubmed: 22956460
Ulasi Ii, Tzur S, Wasser WG et al (2013) High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria. Nephron Clin Pract 123:123–128. https://doi.org/10.1159/000353223
doi: 10.1159/000353223
pubmed: 23860441
Beers K, Wen HH, Saha A, Chauhan K, Dave M, Coca S, Nadkarni G, Chan L (2020) Racial and ethnic disparities in pregnancy-related acute kidney injury. Kidney 360(1):169–178. https://doi.org/10.34067/KID.0000102019
doi: 10.34067/KID.0000102019
Garimella PS, Katz R, Ix JH et al (2017) Association of urinary uromodulin with kidney function decline and mortality: the health ABC study. Clin Nephrol 87:278–286. https://doi.org/10.5414/CN109005
doi: 10.5414/CN109005
pubmed: 28332475
pmcid: 6102560
Wang Y, Du MF, Yao S et al (2021) Associations of serum uromodulin and its genetic variants with blood pressure and hypertension in chinese adults. Front Cardiovasc Med 8:710023. https://doi.org/10.3389/fcvm.2021.710023
doi: 10.3389/fcvm.2021.710023
pubmed: 34869624
pmcid: 8635522
Chakraborty J, Below AA, Solaiman D (2004) Tamm-Horsfall protein in patients with kidney damage and diabetes. Urol Res 32:79–83. https://doi.org/10.1007/s00240-003-0374-6
doi: 10.1007/s00240-003-0374-6
pubmed: 15250099
You R, Zheng H, Xu L et al (2021) Decreased urinary uromodulin is potentially associated with acute kidney injury: a systematic review and meta-analysis. J Intensive care 9:1–11. https://doi.org/10.1186/s40560-021-00584-2
doi: 10.1186/s40560-021-00584-2